GLC-ECD Determination of 1-(2-Hydroxyethyl)- 3-hydroxy-7-chloro-1,3-dihydro-5-(O-fluorophenyl)- 2H-1,4-benzodiazepin-2-one (SAS 643) in Plasma and Urine and Identification of Its Main Biotransformation Products.

Autor: Mardente, Salvatore, Bicchi, Carlo, Nano, G. Mario
Zdroj: Therapeutic Drug Monitoring; 1981, Vol. 3 Issue 4, p351-356, 6p
Databáze: Complementary Index